Eastgate Biotech Corp.
ETBI
$0.00
$0.000.00%
OTC PK
| 09/30/2017 | 06/30/2017 | 03/31/2017 | 12/31/2016 | 09/30/2016 | |
|---|---|---|---|---|---|
| Revenue | 137.60K | 116.20K | 92.50K | 93.60K | 93.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 137.60K | 116.20K | 92.50K | 93.60K | 93.90K |
| Cost of Revenue | 149.20K | 56.90K | -- | -- | -300.00 |
| Gross Profit | -11.60K | 57.60K | -- | -- | 600.00 |
| SG&A Expenses | 3.24M | 1.90M | 1.77M | 2.13M | 2.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.77M | 2.46M | 2.30M | 2.63M | 2.90M |
| Operating Income | -3.63M | -2.35M | -2.30M | -2.63M | -2.90M |
| Income Before Tax | -3.87M | -2.71M | -2.47M | -2.98M | -3.23M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.87 | -2.71 | -2.47 | -2.98 | -3.23 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.87M | -2.71M | -2.47M | -2.98M | -3.23M |
| EBIT | -3.63M | -2.35M | -2.30M | -2.63M | -2.90M |
| EBITDA | -2.21M | -932.60K | -1.35M | -2.58M | -2.85M |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 2.31B | 1.51B | 1.24B | 1.22B | 1.19B |
| Average Diluted Shares Outstanding | 2.31B | 1.51B | 1.24B | 1.22B | 1.19B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |